Abstract
During his studies in Leipzig, more than 100 years ago, Paul Ehrlich described several tissue-bound and blood leukocytes according to their staining properties with basic and azurophilic dyes [1]. One particular cell type in the tissue contained many cytoplasmic granules which stained with a high affinity for certain basic dyes. These cells were located in the connective tissue near blood vessels. The fact that these cells increased in number when the frogs that were studied were put on a highly nutritious diet, and the cells appeared “overfed”, caused Ehrlich to name these “mast cells”, derived from the German word “Mästung” [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ehrlich P (1878) Beiträge zur Theorie and Praxis der histologische Färbung. Thesis. Uni-versity of Leipzig
Ehrlich P (1879) Beiträge zur Kenntnis der granulierten Zellen u.s.w. Verhandlungen der physiol Gesellschaft Berlin 21: 53–60
Schwartz LB, Huff TF (1998) Biology of mast cells. In: E Middleton, EF Ellis, JW Yunginger, CE Reed, NE Adkinson, WW Busse (eds): Allergy. Principles and practice. Mosby Year Book, St. Louis, 261–276
Irani A-MA, Nilsson G, Miettinen U, Craig SS, Ashman LK, Ishizaka T, Zsebo KM, Schwartz LB (1992) Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80: 3009–3021
Mitsui, H, Furitsu T, Dvorak AM, Irani AM, Schwartz LB, Inagaki N, Takei M, Ishiza-ka K, Zsebo MK, Gillis S et al (1993) Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci USA 90: 735–739
Levi-Schaffer F, Rubinchik E (1994) Mast cell/fibroblast interactions. Clin Exp Allergy 24: 1016–1021
Saito H, Ebisawa M, Tachimoto H, Shichijo M, Fukagawa K, Matsumoto K, Iikura Y, Awaji T, Tsujimoto G, Yanagida M et al (1996) Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 157: 343–350
Nilsson G, Miettinen U, Ishizaka T, Ashman LK, Irani A-M, Schwartz LB (1994) Inter-leukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 84: 1519–1527
Czarnetzki BM, Figdor CG, Kolde G, Vroom T, Aalberse RC, de Vries JE (1984) Development of human connective tissue mast cells from purified blood monocytes. Immunology 51: 549–554
Agis H, Willheim M, Sperr WR, Wilfing A, Krömer E, Kabrna E, Spanblöchl E, Strobl H, Geissler K, Spittler A et al (1993) Monocytes do not make mast cells when cultured in the presence of SCF: Characterization of the circulating mast cell progenitor as a c-kit+ CD34+, Ly-, CD14-, CD17-, colony-forming cell. J Immunol 151: 4221–4227
Agis H, Fureder W, Bankl HC, Kundi M, Sperr WR, Willheim M, Boltz Nitulescu G, Butterfield JH, Kishi K, Lechner K, Valent P (1996) Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 87: 535–543
Church MK, Holgate ST, Shute JK, Walls AF, Sampson AP (1998) Mast cell-derived mediators. In: E Middleton, EF Ellis, JW Yunginger, CE Reed, NF Adkinson, WW Busse, (eds): Allergy. Principles and practice. Mosby Year Book, St. Louis, 146–182
Gordon JR, Galli SJ (1990) Mast cells as a source of both preformed and immunologically inducible TNF-a/cachectin. Nature 346: 274–276
Bradding P (1996) Human mast cell cytokines. Clin Exp Allergy 26: 13–19
Siraganian RP (1998) Biochemical event in basophil or mast cell activation and mediator release. In: E Middleton, CE Reed, EF Ellis, NF Adkinson, JW Yunginger, WW Busse (eds): Allergy Principles and practice. Mosby Year Book, St. Louis, 204–227
Dvorak AM, Schleimer RP, Schulman ES, Lichtenstein LM (1986) Human mast cells use conservation and condensation mechanisms during recovery from degranulatio. In vitro studies with mast cells purified from human lungs. Lab Invest 54: 663–678
Metzger H (1991) The high affinity receptor for IgE on mast cells. Clin Exp Allergy 21: 269–279
Coleman JW, Godfrey RC (1981) The number and affinity of IgE receptors on dispersed human lung mast cells. Immunology 44: 859–863
MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, Lichtenstein LM (1997) Serum IgE level drives basophil and mast cell IgE receptor display. Int Arch Allergy Immunol 113: 45–47
Hide M, Francis DM, Grattan CEH, Hakimi J, Kochan JP, Greaves MW (1993) Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328: 1599–1604
Alber G, Miller L, Jelsema CL, Varin-Blank N, Metzger H (1991) Structure-function relationships in the mast cell high affinity receptor for IgE. Role of the cytoplasmic domains and of the beta subunit. J Biol Chem 266: 22613–22620
Rivera VM, Brugge JS (1995) Clustering of Syk is sufficient to induce tyrosine phosphorylation and release of allergic mediators from rat basophilic leukemia cells. Mol Cell Biol 15: 1582–1590
Vivier E, Daëron M (1997) Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 18: 286–291
Scharenberg AM, Kinet J-P (1994) Initial events in FcεRI signal transduction. J Allergy Clin Immunol 94 Suppl: 1142–1146
Lin S, Cicala C, Scharenberg AM, Kinet J (1996) The FcERIbeta subunit functions as an amplifier of FcεRIgamma-mediated cell activation signals. Cell 85: 985–995
Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet J, Capron M (1994) High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367: 183–186
Wang B, Rieger A, Kilgus 0, Ochiai K, Maurer D, Fodinger D, Kinet JP, Stingl G (1992) Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med 175: 1353–1365
Maurer D, Fiebiger S, Ebner C, Reininger B, Fischer GF, Wichlas S, Jouvin MH, Schmitt Egenolf M, Kraft D, Kinet JP, Stingl G (1996) Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha-and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 157: 607–616
Maurer D, Fiebiger E, Reininger B, Wolff Winiski B, Jouvin MH, Kilgus 0, Kinet JP, Stingl G (1994) Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals. J Exp Med 179: 745–750
EI-Lati SG, Dahinden CA, Church MK (1994) Complement peptides C3a-and C5ainduced mediator release from dissociated human skin mast cells. J Invest Dermatol 102: 803–806
Ghannadan M, Baghestanian M, Wimazal F, Eisenmenger M, Latal D, Kargul G, Walchshofer S, Sillaber C, Lechner K, Valent P (1998) Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J Invest Dermatol 111: 689–695
Columbo M, Horowitz EM, Botana LM, MacGlashan DW Jr, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM (1992) Effect of recombinant human c-kit receptor ligand on mediator release from human skin mast cells. Int Arch Allergy Immunol 99: 323–325
Nilsson G, Butterfield JH, Nilsson K, Siegbahn A (1994) Stem cell factor is a chemotactic factor for human mast cells. J Immunol 153: 3717–3723
Church MK, Bradding P, Walls AF, Okayama Y (1997) Human mast cells and basophils. In: AB Kay (ed): Allergy and allergic diseases. Blackwell Science, Oxford, 149–170
Lowman MA, Benyon RC, Church MK (1988) Characterization of neuropeptideinduced histamine release from human dispersed skin mast cells. Br J Pharmacol 95: 121–130
Meade R, Van Lovern H, Parmentier H, Iverson GM, Askenase PW (1988) The antigen-binding T cell factor PCI-F sensitizes mast cells for in vitro release of serotonin: Comparison with monoclonal IgE antibody. J Immunol 141: 2704–2713
Inamura N, Mekori YA, Bhattacharyya SP, Bianchine PJ, Metcalfe DD (1998) Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J Immunol 160: 4026–4033
Bhattacharyya SP, Drucker I, Reshef T, Kirshenbaum AS, Metcalfe DD, Mekori YA (1998) Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J Leukoc Biol 63: 337–341
Malaviya R, Ikeda T, Ross E, Abraham SN (1996) Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381: 77–80
Echtenacher B, Mannel DN, Hultner L (1996) Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381: 75–77
Galli SJ, Wershil BK (1996) The two faces of the mast cell. Nature 381: 21–22
Gauchat J-F, Aubry J-P, Mazzei G, Life P, Jomotte T, Elson G, J-Y Bonnefoy J-Y (1993) Human CD40-ligand: Molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production. FEBS Lett 315: 259–266
Pawankar R, Okuda M, Yssel H, Okumura K, Ra CS (1997) Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcERI, CD4OL, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 99: 1492–1499
Liu FT (1997) Truly MASTerful cells: Mast cells command B cell IgE synthesis. J Clin Invest 99: 1465–1466
Frandji P, Tkaczyk C, Oskeritzian C, David B, Desaymard C, Mecheri S (1996) Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur J Immunol 26: 2517–2528
Love KS, Lakshmanan RR, Butterfield JH, Fox CC (1996) IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1. Cell Immunol 170: 85–90
Frandji P, Tkaczyk C, Oskeritzian C, Lapeyre J, Peronet R, David B, Guillet JG, Mecheri S (1995) Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma. Cell Immunol 163: 37–46
Mecheri S, David B (1997) Unraveling the mast cell dilemma: culprit or victim of its generosity? Immunol Today 5: 212–215
Wang HW, Tedla N, Lloyd AR, Wakefield D, McNeil PH (1998) Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest 8: 1617–1626
De Pater-Huijsen FL, De Riemer MJ, Reijneke RMR, Pompen M, Lutter R, Jansen HM, Out TA (1997) Human mast cells modulate proliferation and cytokine production by CD8+ T lymphocytes. Int Arch Allergy Immunol 113: 287–288
Mihm MC, Soter NA, Dvorak HF, Austen KF (1976) The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67: 305–312
Mitchell EB, Crow J, Williams G, Platts-Mills TAE (1986) Increase in skin mast cells following chronic house dust mite exposure. Br J Dermatol 114: 65–73
Farkas Natbony S, Phillips ME, Elias JM, Godfrey HP, Kaplan AP (1983) Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 2: 177–183
Garriga MM, Friedman MM, Metcalfe DD (1988) A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol 82: 425–432
Irani AM, Schwartz LB (1994) Human mast cell heterogeneity. Allergy Proc 15: 303–308
Okayama Y, Benyon RC, Rees PH, Lowman MA, Hillier K, Church MK (1992) Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy 22: 401–409
Langeveld-Wildschut EG, Thepen T, Bihari IC, Van Reijsen FC, De Vries IJM, Bruijnzeel PLB, Bruijnzeel-Koomen CAFM (1996) Evaluation of the atopy patch test and the cutaneous late-phase reaction as relevant models for the study of allergic inflammation in patients with atopic eczema. J Allergy Clin Immunol 98: 1019–1027
Simons FER (1998) Antihistamines. In: E Middleton, CE Reed, EF Ellis, NF Adkinson, JW Yunginger, WW Busse (eds): Allergy. Principles and practice. Mosby, St. Loius 612–637
Kubes P, Granger DN (1996) Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc Res 32: 699–708
Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF (1991) Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 88: 4220–4224
Ackermann L, Harvima IT (1998) Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM1 in the epidermis. Arch Dermatol Res 290: 353–359
Horsmanheimo L, Harvima IT, Järvikallio A, Harvima RJ, Naukkarinen A, Horsmanheimo M (1994) Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 131: 348–353
Thepen T, Langeveld-Wildschut EG, Bihari IC, van Wichen DF, Van Reijsen FC, Mudde GC, Bruijnzeel-Koomen CAFM (1996) Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 97: 828–837
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Basel AG
About this chapter
Cite this chapter
Knol, E.F. (2000). Mast cells. In: Bruijnzeel-Koomen, C.A.F.M., Knol, E. (eds) Immunology and Drug Therapy of Allergic Skin Diseases. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8464-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8464-8_5
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9579-8
Online ISBN: 978-3-0348-8464-8
eBook Packages: Springer Book Archive